Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Current treatments for alopecia show no significant long-term benefits.

Low iron levels may be linked to some types of hair loss in women.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Gene therapy with the Math1 gene helped regenerate balance-related cells and improve balance in mice.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Researchers found a new gene area linked to male-pattern baldness, which, along with another gene, significantly increases the risk of hair loss in men.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A new gene, JMJD1C, may affect testosterone levels in men.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

ADT, especially enzalutamide, may increase the risk of heart rhythm problems and sudden death in men.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Women have a higher risk of blood clots from hormonal factors and need careful treatment, especially during pregnancy.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Hormone therapy increases the risk of heart-related issues in transgender women and may affect heart health in transgender men.